-
October 8: The Week in Cancer News
A study shows the cost of drugs that manage cancer-related symptoms adds up, and experts explore research at the AACR conference on cancer disparities.
by Marci A. Landsmann
-
October 1: The Week in Cancer News
MRI can be a cost-effective way to screen for breast cancer, and a new study investigates the impact of higher alcohol taxes on cancer incidence
by Kevin McLaughlin
-
Risk in the Air
Air pollution can increase a person's risk of developing cancer, a burden that isn't shared equally in every neighborhood.
by Jon Kelvey
-
Forward Look
What’s Next? Fall 2021Oncolytic viruses to treat pediatric glioma.
by Natalie Slivinski
-
Rethinking Clinical Trials
Could changes spurred by safety concerns during the pandemic make clinical trials more accessible to patients?
by Charlotte Huff
-
Forward Look
Cancer MisinformationBad advice shared online can have a negative effect, even if it's not followed.
by Erin O'Donnell
-
Forward Look
Putting Data to WorkResearchers create breast cancer prediction models tailored for Asian Americans.
by Bradley Jones
-
Forward Look
Spotlight on Small Cell Lung CancerTreatments for small cell lung cancer have remained virtually the same for decades. Now, experts say that hope is on the horizon.
by Isobel Whitcomb
-
Facts and Stats
Looking Closely at Lung CancerWhile there are many kinds of lung cancer, screening recommendations are standard across the board.
by Bradley Jones
-
Healthy Habits
An Alternative to MeatAre new plant-based meat alternatives a better way to satisfy burger cravings?
by Erin O’Donnell
Cancer Talk
Living With Your Loved One’s Prostate Cancer
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
Continuing the ConversationThe AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore